跳至主要内容
临床试验/ACTRN12615001038583
ACTRN12615001038583招募中未知

An Investigator initiated prospective partially blinded study assessing movement, pain and activity in participants undergoing neuro-modulation trials and implantation for failed back surgery syndrome.

Dr Richard Sullivan0 个研究点目标入组 25 人开始时间: 2015年10月7日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1.Males and Females aged over 18
  • 2.FBSS, defined as persistent or re-current low back and leg pain of at least 6 months duration, following at least one decompression and/or fusion procedure
  • 3.Deemed as clinically appropriate for a trial of spinal cord stimulation for the treatment of FBSS
  • 4.Minimum average pain level measured on a numerical rating scale of at least 3
  • 5.Activity limitation as recorded by the Oswestry disability index of > 20%
  • 6.Pain that changes with position or movement
  • 7.Ability to understand and willingness to sign an informed consent statement in English

排除标准

  • 1.Lower back surgery within previous six months.
  • 2.The subject is being currently treated or has been treated with SCS, subcutaneous or peripheral nerve stimulation, intrathecal drug delivery system, or is awaiting further lumbar surgery.
  • 3.Is pregnant or planning to become pregnant during the course of the study;
  • 4.Subjects with a severe hearing impairment or inability to follow verbal instructions.
  • 5.Evidence of non-mechanical contributing cause for lower back pain e.g. neoplasm, infection, fracture, inflammatory disorder or persistent non-fluctuating pain.
  • 6.Implanted electrical medical device that would conflict with either the spinal cord stimulator implant or the measurement technology
  • 7.Significant medical or psychological abnormalities/conditions, a history of substance abuse or recent history of a medical-surgical intervention that in the opinion of the investigator would interfere either with the ability to complete the study or the assessments.
  • 8.Known allergy skin reaction to tapes and plasters.
  • 9.Subject who is currently enrolled in an investigational drug or device study
  • 10.Inability to operate the SCS equipment, comply with study requirements or complete questionnaires in English independently.

研究者

发起方
Dr Richard Sullivan

相似试验

已完成
4 期
An Investigator Initiated, Controlled, Prospective, Non-Inferiority, Parallel-Group, randomised, Interventional, Open, Blinded Outcome Assessment (PROBE-Design), Multi-centre Trial, Comparing Efficacy and Safety of Isolation of the Pulmonary Veins with a Cryoballoon Catheter Versus a Radiofrequency Ablation with a ThermoCool Catheter in Patients with Paroxysmal Atrial FibrillatioParoxysmal atrial fibrillationirregular heart beat10007521
NL-OMON39146FGK Representative Service GmbH114
终止
不适用
Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Magnetic Resonance Imaging (MRI) Sub-study: Effect of intensive blood pressure lowering treatment provided by a Triple Pill strategy on chronic markers of cerebral small vessel disease in patients with a history of acute stroke due to intracerebral haemorrhage, as assessed by Magnetic Resonance Imaging.Stroke caused by Intracerebral Haemorrhage (ICH)Cerebral Small Vessel DiseaseStroke - HaemorrhagicCardiovascular - HypertensionNeurological - Other neurological disordersHypertension
ACTRN12618001977268The George Institute for Global Health4
终止
不适用
Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study: Effectiveness of intensive long-term blood pressure lowering treatment, provided by a Triple Pill strategy, for slowing memory decline as measured by Cambridge Neuropsychological Test Automated Battery (CANTAB), in patients with a history of acute stroke due to intracerebral haemorrhage.HypertensionDementia
ACTRN12618001677291The George Institute1
终止
不适用
A randomised controlled trial of a non-invasive injection site desensitiser device for use in blood donation. Part 2: EfficacyBlood Donation
ACTRN12618000099224Australian Red Cross Blood Service450
招募中
1 期
Trail with Corneal Implant
CTRI/2019/07/020024Eye Yon Medical Ltd